Bilingual English/Spanish GLP-1 weight loss care. Compounded semaglutide and tirzepatide — all-inclusive, transparent pricing. Real humans who answer the phone. Zero data breaches. Women's health from day one. Starting at $169/month.
¿Prefieres el español? REMEVi es la primera plataforma de semaglutida y pérdida de peso completamente bilingüe de los EE.UU. — atención GLP-1 en español.
An honest side-by-side comparison on compounded semaglutide pricing, tirzepatide access, data security, and bilingual weight loss support — using publicly available data as of April 2026.
| Feature | REMEVi | MEDVi |
|---|---|---|
| GLP-1 semaglutide (injectable) | $169 intro / $279 ongoing — all-inclusive | $179 intro / $299 ongoing |
| Hidden fees or separate billing | None. All-inclusive pricing, always | Reported billing surprises and double charges |
| Spanish language support | Full bilingual English + Spanish — every touchpoint | English only |
| Women's health | Full program — GLP-1, HRT, hair, skin, mental health | Partial — women's health listed as limited |
| Data security | Zero breaches. HIPAA certified. | 1.6M patient breach (OpenLoop, Jan 2026) |
| FDA status | LegitScript certified. Full FDA compliance. | FDA warning letter issued 2026 |
| Legal / regulatory issues | None | Named in federal class action lawsuit (RICO) |
| Human phone support | Yes — bilingual coordinators, 2-hour response | Primarily automated. BBB complaints cite unresponsive support. |
| Cancellation policy | One-click, instant, no penalty | BBB complaints about cancellation difficulty |
| BBB rating | A+ (target) | F rating, 361 complaints |
| Before/after photos | Real patients only. No AI-generated images. | Deepfake before/after photos reported (Futurism) |
| Mobile app | Bilingual app — progress, reminders, 1:1 video (Phase 2) | Web portal only |
*Comparison based on publicly available information, BBB records, FDA records, court filings, and customer reviews as of April 2026. MEDVi is a trademark of MEDVi LLC.
Three platforms. Zero Spanish. Zero bilingual support. None of them built for the 65 million Americans who speak Spanish at home and need affordable semaglutide, tirzepatide, and GLP-1 weight loss care. We did.
Every intake form, every patient message, every support call — in English or Spanish from the first word. Not Google Translated. Built bilingual.
First in the USHims charges $145/month before you get a single pill. Ro has a $45 bait-and-switch. REMEVi shows you the real all-inclusive price before you pay a cent.
What you see = what you pay"You are NOT communicating with real medical providers" — that's an actual Hers customer review. REMEVi has bilingual care coordinators with a 2-hour response guarantee.
2-hour response SLAMEDVi has had "Women's Health — Coming Soon" for over a year. REMEVi launched with a full women's program: GLP-1, HRT, hair, skin, and mental health.
MEDVi's biggest gapIn 2026, both MEDVi's partner and Hims & Hers confirmed major data breaches. REMEVi uses only HIPAA-certified infrastructure with a clean security record.
Zero breachesLegitScript certification means Google, Meta, and TikTok verify us as a legitimate healthcare platform. It's the same standard that MEDVi couldn't maintain.
Verified & compliantEverything included — physician review, compounded semaglutide or tirzepatide medication, free shipping, and bilingual support. The most affordable GLP-1 weight loss program available in English and Spanish. Pay less than MEDVi, Ro, or Hims and get more.
These are documented events from public records, federal filings, and verified news sources — not opinions.
The FDA issued a warning letter to MEDVi for claiming their compounded products contained "the same active ingredient" as FDA-approved drugs like Ozempic and Wegovy — a violation of federal advertising rules.
A threat actor breached OpenLoop Health's systems and exfiltrated records from approximately 1.6 million patients, including names, contact information, dates of birth, and medical information.
A federal class action complaint alleges MEDVi was one of dozens of telehealth storefronts selling compounded oral tirzepatide with "no demonstrated mechanism of absorption or efficacy" — calling it "modern-day snake oil."
Complaints center on cancellation difficulty, unexpected charges, unresponsive support, and billing after cancellation. The company has an F rating — the lowest possible BBB grade.
REMEVi was built specifically in response to these failures. We are not affiliated with MEDVi, OpenLoop Health, or any of their partners. We exist to be the alternative patients deserve.
Every GLP-1 telehealth platform in America — MEDVi, Hims, Ro — is English only. None offer compounded semaglutide, tirzepatide, or Ozempic alternatives in Spanish. REMEVi is the first to serve the 65 million Spanish-speaking Americans who've been left out of the weight loss medication and GLP-1 peptide revolution.
Get started in English →REMEVi es la primera plataforma de salud GLP-1 completamente bilingüe en los EE.UU. Atención médica real, en español — desde la consulta hasta el seguimiento.
Empieza en español →GLP-1 (glucagon-like peptide-1) is a naturally occurring hormone your body produces after eating. It signals your brain to feel full, slows digestion, and helps regulate blood sugar. Compounded semaglutide — the active ingredient in Ozempic and Wegovy — is a GLP-1 receptor agonist: a peptide medication that mimics this hormone, helping you eat less and lose weight sustainably under physician supervision.
Tirzepatide (the active ingredient in Mounjaro and Zepbound) is a dual GLP-1/GIP agonist — a newer class of peptide that targets two hormonal pathways simultaneously, producing greater average weight loss than semaglutide alone in clinical trials.
Brand-name versions like Ozempic, Wegovy, Mounjaro, and Zepbound cost $900–$1,500/month without insurance. Compounded semaglutide and compounded tirzepatide — available through telehealth platforms like REMEVi — contain the same active peptide molecules at a fraction of the cost, manufactured by licensed US compounding pharmacies.
REMEVi offers compounded semaglutide from $169/month and compounded tirzepatide from $289/month — fully bilingual in English and Spanish, all-inclusive with physician review and free shipping. Check your eligibility today.
Bilingual telehealth. Transparent pricing. Real care. Starting at $169/month all-inclusive.
No insurance needed · Cancel anytime · LegitScript certified · HIPAA compliant
Available in NV, CA, TX, FL, NY — more states coming soon